Release Date: February 28, 2012
The National Institute on Drug Abuse maintains a strong interest in studies on tobacco use and HIV/AIDS despite the expiration of PA-08-253 (R01) and PA-08-254 (R03), “Unique Interactions Between Tobacco Use and HIV/AIDS,” which will not be reissued. Using other NIDA or parent FOAs, applicants are encouraged to submit research applications addressing the intersection of nicotine or tobacco use and HIV/AIDS, including animal and human preclinical, treatment, epidemiology, and prevention studies.
Jag H. Khalsa, Ph.D.
Chief, Medical Consequences Branch
Division of Pharmacotherapies and Medical
Consequences of Drug Abuse (DPMC)
National Institute on Drug Abuse, NIH
Telephone: (301) 443-2159 (direct)
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)